147 related articles for article (PubMed ID: 8761844)
1. A dose-effect study of beraprost sodium in intermittent claudication.
Lievre M; Azoulay S; Lion L; Morand S; Girre JP; Boissel JP
J Cardiovasc Pharmacol; 1996 Jun; 27(6):788-93. PubMed ID: 8761844
[TBL] [Abstract][Full Text] [Related]
2. Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin I2 analogue: a double-blinded, randomized, controlled trial.
Mohler ER; Hiatt WR; Olin JW; Wade M; Jeffs R; Hirsch AT
J Am Coll Cardiol; 2003 May; 41(10):1679-86. PubMed ID: 12767646
[TBL] [Abstract][Full Text] [Related]
3. Oral Beraprost sodium, a prostaglandin I(2) analogue, for intermittent claudication: a double-blind, randomized, multicenter controlled trial. Beraprost et Claudication Intermittente (BERCI) Research Group.
Lièvre M; Morand S; Besse B; Fiessinger JN; Boissel JP
Circulation; 2000 Jul; 102(4):426-31. PubMed ID: 10908215
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of oral beraprost sodium, a prostaglandin I2 analogue, for treating intermittent claudication in patients with arteriosclerosis obliterans.
Matsumoto T; Iwasa K; Kyuragi R; Honma K; Guntani A; Ohmine T; Itoh H; Onohara T; Maehara Y
Int Angiol; 2010 Apr; 29(2 Suppl):49-54. PubMed ID: 20357749
[TBL] [Abstract][Full Text] [Related]
5. Studies on the effectiveness and safety of cilostazol, beraprost sodium, prostaglandin E1 for the treatment of intermittent claudication.
Hashiguchi M; Ohno K; Saito R
Yakugaku Zasshi; 2004 Jun; 124(6):321-32. PubMed ID: 15170067
[TBL] [Abstract][Full Text] [Related]
6. A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial.
Beebe HG; Dawson DL; Cutler BS; Herd JA; Strandness DE; Bortey EB; Forbes WP
Arch Intern Med; 1999 Sep; 159(17):2041-50. PubMed ID: 10510990
[TBL] [Abstract][Full Text] [Related]
7. Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension.
Melian EB; Goa KL
Drugs; 2002; 62(1):107-33. PubMed ID: 11790158
[TBL] [Abstract][Full Text] [Related]
8. Prostanoids for intermittent claudication.
Robertson L; Andras A
Cochrane Database Syst Rev; 2013 Apr; (4):CD000986. PubMed ID: 23633305
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of intermittent claudication due to spinal canal stenosis using beraprost sodium, a stable prostaglandin I2 analogue. A case report.
Kato H; Emura S; Ngashima K; Kishikawa H; Takashima T; Ohmori K
Angiology; 1997 May; 48(5):457-61. PubMed ID: 9158390
[TBL] [Abstract][Full Text] [Related]
10. Platelet-aggregation inhibition and hemodynamic effects of beraprost sodium, a new oral prostacyclin derivative: a study in healthy male subjects.
Nony P; Ffrench P; Girard P; Delair S; Azoulay S; Girre JP; Dechavanne M; Boissel JP
Can J Physiol Pharmacol; 1996 Aug; 74(8):887-93. PubMed ID: 8960377
[TBL] [Abstract][Full Text] [Related]
11. Beraprost therapy for pulmonary arterial hypertension.
Barst RJ; McGoon M; McLaughlin V; Tapson V; Rich S; Rubin L; Wasserman K; Oudiz R; Shapiro S; Robbins IM; Channick R; Badesch D; Rayburn BK; Flinchbaugh R; Sigman J; Arneson C; Jeffs R;
J Am Coll Cardiol; 2003 Jun; 41(12):2119-25. PubMed ID: 12821234
[TBL] [Abstract][Full Text] [Related]
12. Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial.
Galiè N; Humbert M; Vachiéry JL; Vizza CD; Kneussl M; Manes A; Sitbon O; Torbicki A; Delcroix M; Naeije R; Hoeper M; Chaouat A; Morand S; Besse B; Simonneau G;
J Am Coll Cardiol; 2002 May; 39(9):1496-502. PubMed ID: 11985913
[TBL] [Abstract][Full Text] [Related]
13. A long-term study of policosanol in the treatment of intermittent claudication.
Castaño G; Más Ferreiro R; Fernández L; Gámez R; Illnait J; Fernández C
Angiology; 2001 Feb; 52(2):115-25. PubMed ID: 11228084
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacological and clinical properties of beraprost sodium, orally active prostacyclin analogue].
Nishio S; Kurumatani H
Nihon Yakurigaku Zasshi; 2001 Feb; 117(2):123-30. PubMed ID: 11233303
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of beraprost sodium on Raynaud's phenomenon in patients with systemic sclerosis].
Kaburaki J; Kuwana M; Akizuki M; Takano M; Tojo T
Nihon Rinsho Meneki Gakkai Kaishi; 1995 Feb; 18(1):29-35. PubMed ID: 7553036
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of beraprost sodium on arteriosclerosis obliterans: a single-center retrospective study of Japanese patients.
Arai T
Adv Ther; 2013 May; 30(5):528-40. PubMed ID: 23749750
[TBL] [Abstract][Full Text] [Related]
17. Effects of beraprost sodium (Dorner) in patients with diabetes mellitus complicated by chronic arterial obstruction.
Toyota T; Oikawa S;
Angiology; 2002; 53(1):7-13. PubMed ID: 11863312
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of the efficacy of ginkgo biloba special extract EGb 761 on intermittent claudication--a placebo-controlled, double-blind multicenter trial.
Peters H; Kieser M; Hölscher U
Vasa; 1998 May; 27(2):106-10. PubMed ID: 9612115
[TBL] [Abstract][Full Text] [Related]
19. Beraprost for the treatment of intermittent claudication.
Cooper LT
J Am Coll Cardiol; 2003 May; 41(10):1687-9. PubMed ID: 12767647
[No Abstract] [Full Text] [Related]
20. The effect of withdrawal of drugs treating intermittent claudication.
Dawson DL; DeMaioribus CA; Hagino RT; Light JT; Bradley DV; Britt KE; Charles BE
Am J Surg; 1999 Aug; 178(2):141-6. PubMed ID: 10487267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
